<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>1</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2015</Year><Month>12</Month><Day>28</Day></PubDate></Journal><title locale="en_US">Preventive Role of Endothelin Antagonist on Kidney Ischemia: Reperfusion Injury in Male and Female Rats</title><FirstPage>1621</FirstPage><LastPage>1621</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan &amp; Department of Physiology, Faculty of Medicine, Isfahan University of&#13;
Medical Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Department of Clinical Pathology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>28</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;strong&gt;Background:&lt;/strong&gt; Renal ischemia/reperfusion injury (RIRI) is the most common cause of acute kidney injury. We tested the protective role of endothelin‑1 receptor blocker; bosentan (BOS) in animal model of RIRI in two different genders.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods:&lt;/strong&gt; Male and female Wistar rats were assigned as sham operated (sham), control group (ischemia), and case group (ischemia + BOS) treated with BOS (50 mg/kg) 2 h before bilateral kidney ischemia induced by clamping renal vessels for 45 min followed by 24 h of renal reperfusion.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results:&lt;/strong&gt; The RIRI significantly increased the serum levels of blood urea nitrogen and creatinine in both genders (P &amp;lt; 0.05). These values were significantly decreased by BOS in both genders. In male rats, the serum levels of malondialdehyde in the ischemia + BOS group were decreased significantly when compared with ischemia group (P &amp;lt; 0.05).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions:&lt;/strong&gt; BOS can be used in both genders to attenuate kidney ischemia injury possibly&lt;br /&gt;due to its effect in the renal vascular system.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Keywords:&lt;/strong&gt; Bosentan, endothelin, gender, ischemia‑reperfusion, kidney&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/1621</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/1621/1912</pdf_url></Article></Articles>
